Ibis Biosciences Inc.

The fight against infectious disease presents a revealing truth to medical practice: as hard as it is to understand the intricate variations in the life cycle of a single pathogen, it is harder still

The high cost of health care-associated infections (HAIs), a growing incidence of antibiotic-resistant organisms, public reporting of hospital infection rates, and pay-for-performance initiatives that

The high cost of health care-associated infections (HAIs), a growing incidence of antibiotic-resistant organisms, public reporting of hospital infection rates, and pay-for-performance initiatives that

In its last few earnings calls, Ionis Pharmaceuticals Inc. has touched on a significant change in its partnering strategy. We spoke with CEO Stan Crooke recently to better understand the implicati